Blue Jet Healthcare FY26 Annual Report & AGM Notice Released
Blue Jet Healthcare Ltd. has released its Annual Report for the financial year 2025-26, along with the notice for its 58th Annual General Meeting (AGM) scheduled for September 21, 2026. The report details the company's transition into a strategic CDMO partner, emphasizing its "Collaboration, Development, Manufacturing" approach. Key operational highlights include the agreement to purchase 102.48 acres of industrial land in Andhra Pradesh for a new manufacturing facility for ₹435.02 million and securing a lease for an additional R&D center in Hyderabad focused on emerging technologies like GLP-1 intermediates and peptide chemistry. The company is investing in R&D, manufacturing capacity, and advanced capabilities to meet evolving global healthcare needs.
Key Highlights
- Annual Report for FY 2025-26 and AGM notice published.
- Acquiring 102.48 acres for new manufacturing facility in Andhra Pradesh.
- Expanding R&D capabilities with a new center in Hyderabad.
- Focusing on strategic CDMO partnership and advanced drug development.
- AGM to be held on September 21, 2026, via Video Conferencing.
Price Impact
More from BLUEJET